Developing Best-in-Class Radiopharmaceuticals for Cancer Patients

from Rx for Biotech · host Podcast Host Chris Leidli

Our guests for this podcast episode are the co-founders of Ratio Therapeutics, CEO Jack Hoppin, PhD, and Chief Scientific Officer, John Babich, PhD. Ratio Therapeutics's mission is to develop best-in-class radiopharmaceuticals for the treatment of cancers.

Episode metadata supplied by the publisher feed · Published Sep 19, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Developing Best-in-Class Radiopharmaceuticals for Cancer Patients

0:00 28:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

#207 13 actionable pieces of mental health advice from six former podcast guests

Dec 12, 2025 ·53m

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 28 minutes long.

When was this Rx for Biotech episode published?

This episode was published on September 19, 2023.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!